STOCK TITAN

Nayax CLO Omer Gal sells 1,750 shares after exercise

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Nayax Ltd. CLO Omer Gal exercised options to acquire 1,250 ordinary shares and 500 ordinary shares on November 17, 2026, at a reported exercise price of $21.352 per share. The exercise price is denominated in New Israeli Shekels; the reported U.S. dollar amount reflects the grant-date exchange rate. Gal sold the acquired shares that day: 1,250 shares at a weighted-average reported price of $49.7319 per share and 500 shares at a weighted-average reported price of $49.9183 per share. Both sales were on the Tel Aviv Stock Exchange in New Israeli Shekels, at an exchange rate of 3.246 ILS to $1.000. No Rule 10b5-1 plan is reported.

Insider Omer Gal
Role CLO
Sold 1,750 shs ($87K)
Approx. gross sale proceeds $87K
Approx. exercise cost $37K
Approx. pre-tax spread $50K
Share of Position Sold 8.6%
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F2, F1 1,250 $0.00 $0.00
Exercise Stock Option (Right to Buy) F2, F1 500 $0.00 $0.00
Exercise Ordinary Shares F3, F5 1,250 $21.352 $27K
Sale Ordinary Shares F4, F6 1,250 $49.7319 $62K
Exercise Ordinary Shares F3, F5 500 $21.352 $11K
Sale Ordinary Shares F4, F7 500 $49.9183 $25K
Holdings After Transaction: Stock Option (Right to Buy) — 0 options (Direct); Ordinary Shares — 18,539 shares (Direct)
Holdings Before and After: Stock Option (Right to Buy), 1,750 to 0 options (Direct); Ordinary Shares, 18,539 to 18,539 shares (Direct)
Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (7)
  1. F1. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
  2. F2. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
  3. F3. The shares were acquired upon the exercise of stock options
  4. F4. The shares sold were acquired upon the exercise of stock options on the same date
  5. F5. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
  6. F6. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $49.1374 to $49.8768. These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS). The exchange rate in effect on the transaction date was 3.246 ILS to $1.000 . The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request
  7. F7. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $49.846 to $49.9692. These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS). The exchange rate in effect on the transaction date was 3.246 ILS to $1.000 . The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request
Options exercised 1,250 ordinary shares November 17, 2026; options expire March 28, 2027.
Options exercised 500 ordinary shares November 17, 2026; options expire November 22, 2026.
Exercise price $21.352 per share Denominated in New Israeli Shekels; reported U.S. dollar amount reflects the grant-date exchange rate.
Shares sold 1,250 shares November 17, 2026; weighted-average reported price of $49.7319 per share.
Shares sold 500 shares November 17, 2026; weighted-average reported price of $49.9183 per share.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
exercise price financial
"The exercise price is denominated in New Israeli Shekels."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Nayax (NYAX) shares did Omer Gal sell, and at what prices?

Omer Gal sold 1,250 shares at a weighted-average reported price of $49.7319 per share and 500 shares at $49.9183 per share on November 17, 2026. The sales were conducted on the Tel Aviv Stock Exchange in New Israeli Shekels; the reported exchange rate was 3.246 ILS to $1.000.

When did Omer Gal’s Nayax (NYAX) options expire?

The options covering 1,250 shares expire March 28, 2027, and those covering 500 shares expire November 22, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Omer Gal

(Last)(First)(Middle)
3 ARIK EINSTEIN ST.
BUILDING B

(Street)
HERZILYA4659071

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nayax Ltd. [ NYAX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CLO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares11/17/2026M1,250(3)A$21.352(5)19,789D
Ordinary Shares11/17/2026S1,250(4)D$49.7319(6)18,539D
Ordinary Shares11/17/2026M500(3)A$21.352(5)19,039D
Ordinary Shares11/17/2026S500(4)D$49.9183(7)18,539D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$21.352(2)11/17/2026M(1)1,25003/28/202303/28/2027Ordinary Shares1,250$00D
Stock Option (Right to Buy)$21.352(2)11/17/2026M(1)50008/22/202211/22/2026Ordinary Shares500$00D
Explanation of Responses:
1. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
2. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
3. The shares were acquired upon the exercise of stock options
4. The shares sold were acquired upon the exercise of stock options on the same date
5. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
6. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $49.1374 to $49.8768. These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS). The exchange rate in effect on the transaction date was 3.246 ILS to $1.000 . The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request
7. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $49.846 to $49.9692. These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (ILS). The exchange rate in effect on the transaction date was 3.246 ILS to $1.000 . The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request
/s/ Yohanan Azriel on behalf of Oppenheimer Israel, as Attorney-in-fact11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading